- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BIIB
Recent news which mentions BIIB
What Investors Should Like About Eli Lilly's Q3 Update
November 04, 2021
From Motley Fool
Healthcare Stocks Subject to Government Policy
November 02, 2021
From Benzinga
Cassava Stock Could Jump More Than 200 Times
November 01, 2021
From InvestorPlace
Biogen Beat Earnings and Raised Guidance. Here's Why I Still Wouldn't Buy the Stock
October 29, 2021
Tickers
BIIB
From Motley Fool
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
October 28, 2021
From Motley Fool
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
From Motley Fool
10 Biggest Price Target Changes For Tuesday
October 26, 2021
From Benzinga
Was Atea Pharmaceutical's Flop Predictable?
October 26, 2021
From Motley Fool
3 Big Problems With Biogen's Q3 Results
October 23, 2021
From Motley Fool
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
October 22, 2021
From Motley Fool
10 Biggest Price Target Changes For Thursday
October 21, 2021
From Benzinga
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
October 20, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
2 Stocks That Could Grow Your Portfolio Over the Next Decade
October 20, 2021
From Motley Fool
3 Biotech Stocks That Are Ridiculously Overpriced
October 20, 2021
From Motley Fool
From MarketWatch
Earnings Scheduled For October 20, 2021
October 20, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
Here’s ‘one of the most bullish signals’ ever for bitcoin that many investors may have missed
October 18, 2021
From MarketWatch
The Dow is on track for its best October in 6 years and third-quarter earnings are strong so far. What could go wrong?
October 16, 2021
From MarketWatch
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.